Market By Type, Substrate Material, End Users And Geography | Forecasts 2019-2027
After a detailed analysis, Triton has concluded that the global biochips market is expected to display an upward trend in terms of revenue and is estimated to grow at a CAGR of 19.32% from 2019 to 2027. The market was assessed to be worth $11136.62 million in the year 2018 and is predicted to generate a revenue of approximately $52833.98 million by the year 2027.
Biochips are the gathering of diminished test sites or microarrays that are arranged on a solid underlying layer that allows to perform a variety of tests at the same time for better throughput and speed. Specifically, a biochip's surface area is smaller than or equal to a fingernail. Similar to a computer chip that has the ability to perform several mathematical procedures in a second, a biochip possesses the capability of accomplishing a variety of biological reactions (such as decoding genes) in few seconds.
We provide additional customization based on your specific requirements. Request For Customization
Digital microfluidic biochips have become one of the rising technologies in various biomedical fields. In this technology, a group of adjacent cells in the microfluidic array can be configured to work as storage, functional operations and also for transporting fluid droplets dynamically.
The sensors are placed on a flat inner layer that can be passive like silicon or glass or active, including integrated electronics or micromechanical devices that execute or aids the signal transduction, which can be analyzed later. By using surface chemistry, the sensor molecules are bound to the substrate with the help of covalent. The production of microarrays, which is non-trivial and an acute economic and technological restraint can decide the future of biochips.
The process of placing each sensor at a specific position (typically on a Cartesian grid) on the substrate is the primary manufacturing challenge. Out of various means which exist to achieve the placement, the robotic micro-pipetting or micro-printing systems are used to place tiny spots of sensor material on the chip surface. As each sensor is unique, only a few spots can be placed at a time.
In the biochips market report from Triton, market definition and the key insights regarding the industry are discussed. Also, the market attractiveness matrix, vendor scorecard, Porter's five force analysis, key impact analysis, industrial components, regulatory framework, market opportunity insights, industrial player positioning and key market strategies are studied in detail.
The market drivers like growth in personalized medicines market, rising incidences and treatment of cancer, the global increase in the spending on healthcare and rising investments in biotechnology R&D are analyzed in the report. The industry is facing market restraints like inequality in healthcare access, inadequate technical awareness related to biochips and complexity of biological systems are some of the obstructing factors for the growth of the market.
To get detailed insights on segments, Request Free Sample Report
The key opportunities like developments in biochips technology, lucrative growth in the Asia-Pacific region and growing application areas of biochips can be leveraged by the industry to reach towards the projected growth over the forecasting years. However, challenges such as availability of substitute technology, unclear regulatory guideline and cost constraints are restricting the growth in the market.
The key geographies covered in the biochips market are:
o North America Biochips Market: United States and Canada
o Europe Biochips Market: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe
o Asia Pacific Biochips Market: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia Pacific
o Latin America Biochips Market: Brazil, Mexico and Rest of Latin America
o The Middle East and Africa Biochips Market: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East and Africa
The global biochips market is segmented as follows:
• The type segment includes:
o DNA chips:
• Agricultural biotechnology
• Cancer diagnostics and treatment
• Drug discovery
• Gene expression
• Genomics
• Single nucleotide polymorphism (SNP) genotyping
• Other DNA chips
o Lab on a chip:
• Clinical Diagnostics
• Drug discovery
• Genomics
• Point of care and In vitro diagnosis
• Proteomics
• Other lab on a chip
o Protein chips:
• Diagnostics
• Drug discovery
• Expression profiling
• High throughput screening
• Proteomics
• Other protein chips
o Other chips:
• Cell arrays
• Tissue arrays
• The substrate material segment includes:
o Glass
o Polymers
o Silicon
o Other substrate materials
• The end users segment includes:
o Biotechnology and pharmaceutical companies
o Hospital and diagnostics centers
o Academic and research institute
The dominant players in the biochips market include Agilent Technology Inc., Cybrdi Inc., Biochain Institute Inc., Fluidigm Corporation, Biomerieux SA, Gamida for Life Group, Bio-rad Laboratories Inc., Illumina Inc., Cepheid Inc., and Imgenex.
The strategic analysis for each of these companies in the biochips market is covered in detail. The company market share helps to dive into the information about the key players and their hold on the market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. BIOCHIPS
MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.3. EVOLUTION
& TRANSITION OF BIOCHIPS
2.4. PORTER'S
FIVE FORCE ANALYSIS
2.5. MARKET
ATTRACTIVENESS MATRIX
2.6. INDUSTRY
COMPONENTS
2.7. REGULATORY
FRAMEWORK
2.8. VENDOR
SCORECARD
2.9. KEY
IMPACT ANALYSIS
2.10.
MARKET OPPORTUNITY INSIGHTS
2.11.
INDUSTRY PLAYER POSITIONING
2.12.
KEY MARKET STRATEGIES
2.13.
MARKET DRIVERS
2.13.1.
GROWTH IN PERSONALIZED
MEDICINES
2.13.2.
RISING INCIDENCES &
TREATMENT OF CANCER
2.13.3.
CONSTANT RISE IN HEALTHCARE
SPENDING WORLDWIDE
2.13.4.
INCREASING NUMBER OF
INVESTMENTS IN BIOTECHNOLOGY R&D
2.14.
MARKET RESTRAINTS
2.14.1.
INEQUALITIES IN HEALTHCARE
ACCESS
2.14.2.
INADEQUATE TECHNICAL AWARENESS
RELATED TO BIOCHIPS
2.14.3.
COMPLEXITY OF BIOLOGICAL
SYSTEMS
2.15.
MARKET OPPORTUNITIES
2.15.1.
DEVELOPMENTS IN BIOCHIPS
TECHNOLOGY
2.15.2.
ASIA PACIFIC TO OFFER
LUCRATIVE GROWTH OPPORTUNITIES
2.15.3.
WIDENING APPLICATION AREAS OF
BIOCHIPS
2.16.
MARKET CHALLENGES
2.16.1.
AVAILABILITY OF SUBSTITUTE
TECHNOLOGIES
2.16.2.
UNCLEAR REGULATORY GUIDELINES
2.16.3.
COST CONSTRAINTS
3. BIOCHIPS
INDUSTRY OUTLOOK – BY TYPE
3.1. DNA
CHIPS
3.1.1. AGRICULTURAL
BIOTECHNOLOGY
3.1.2. CANCER
DIAGNOSTICS & TREATMENT
3.1.3. DRUG
DISCOVERY
3.1.4. GENE
EXPRESSION
3.1.5. GENOMICS
3.1.6. SINGLE
NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING
3.1.7. OTHER
DNA CHIPS
3.2. LAB
ON A CHIP
3.2.1. CLINICAL
DIAGNOSTICS
3.2.2. DRUG
DISCOVERY
3.2.3. GENOMICS
3.2.4. POINT
OF CARE & IN VITRO DIAGNOSIS
3.2.5. PROTEOMICS
3.2.6. OTHER
LAB ON A CHIP
3.3. PROTEIN
CHIPS
3.3.1. DIAGNOSTICS
3.3.2. DRUG
DISCOVERY
3.3.3. EXPRESSION
PROFILING
3.3.4. HIGH
THROUGHPUT SCREENING
3.3.5. PROTEOMICS
3.3.6. OTHER
PROTEIN CHIPS
3.4. OTHER
CHIPS
3.4.1. CELL
ARRAYS
3.4.2. TISSUE
ARRAYS
4. BIOCHIPS
INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL
4.1. GLASS
4.2. POLYMERS
4.3. SILICON
4.4. OTHER
SUBSTRATE MATERIALS
5. BIOCHIPS
INDUSTRY OUTLOOK - BY END USER
5.1. BIOTECHNOLOGY
AND PHARMACEUTICAL COMPANIES
5.2. HOSPITALS
AND DIAGNOSTICS CENTERS
5.3. ACADEMIC
AND RESEARCH INSTITUTE
6. BIOCHIPS
INDUSTRY - REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY TYPE
6.1.2. MARKET
BY SUBSTRATE MATERIAL
6.1.3. MARKET
BY END USER
6.1.4. COUNTRY
ANALYSIS
6.1.4.1. UNITED
STATES
6.1.4.2. CANADA
6.2. EUROPE
6.2.1. MARKET
BY TYPE
6.2.2. MARKET
BY SUBSTRATE MATERIAL
6.2.3. MARKET
BY END USER
6.2.4. COUNTRY
ANALYSIS
6.2.4.1. UNITED
KINGDOM
6.2.4.2. GERMANY
6.2.4.3. FRANCE
6.2.4.4. ITALY
6.2.4.5. SPAIN
6.2.4.6. RUSSIA
6.2.4.7. REST
OF EUROPE
6.3. ASIA
PACIFIC
6.3.1. MARKET
BY TYPE
6.3.2. MARKET
BY SUBSTRATE MATERIAL
6.3.3. MARKET
BY END USER
6.3.4. COUNTRY
ANALYSIS
6.3.4.1. CHINA
6.3.4.2. JAPAN
6.3.4.3. INDIA
6.3.4.4. SOUTH
KOREA
6.3.4.5. ASEAN
COUNTRIES
6.3.4.6. AUSTRALIA
AND NEW ZEALAND
6.3.4.7. REST
OF ASIA PACIFIC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY TYPE
6.4.2. MARKET
BY SUBSTRATE MATERIAL
6.4.3. MARKET
BY END USER
6.4.4. COUNTRY
ANALYSIS
6.4.4.1. BRAZIL
6.4.4.2. MEXICO
6.4.4.3. REST
OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY TYPE
6.5.2. MARKET
BY SUBSTRATE MATERIAL
6.5.3. MARKET
BY END USER
6.5.4. COUNTRY
ANALYSIS
6.5.4.1. UNITED
ARAB EMIRATES
6.5.4.2. TURKEY
6.5.4.3. SAUDI
ARABIA
6.5.4.4. SOUTH
AFRICA
6.5.4.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. AGILENT
TECHNOLOGY INC.
7.2. BIOCHAIN
INSTITUTE INC.
7.3. BIOMERIEUX
SA
7.4. BIO-RAD
LABORATORIES INC.
7.5. CEPHEID
INC.
7.6. CYBRDI
INC.
7.7. FLUIDIGM
CORPORATION
7.8. GAMIDA
FOR LIFE GROUP
7.9. ILLUMINA
INC.
7.10.
IMGENEX
7.11.
MERCK GMBH
7.12.
ORIGENE TECHNOLOGIES INC.
7.13.
PERKINELMER INC.
7.14.
SAMSUNG ELECTRONICS INC.
7.15.
THERMO FISHER SCIENTIFIC INC.
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1. MARKET
ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET
TABLE 2. VENDOR
SCORECARD OF BIOCHIPS MARKET
TABLE 3. REGULATORY
FRAMEWORK OF BIOCHIPS MARKET
TABLE 4. KEY STRATEGIC
DEVELOPMENTS IN BIOCHIPS MARKET
TABLE 5. ESTIMATED
NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN UNITED
STATES IN 2017
TABLE 6. NOTABLE
INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017
TABLE 7. ESTIMATED
R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF THE UNITED STATES,
2013-2015 (IN $ MILLIONS)
TABLE 8. ESTIMATED
R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF
UNITED STATES, 2013-2015 (IN $ MILLIONS)
TABLE 9. GLOBAL
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 10. GLOBAL
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 11. GLOBAL
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 12. GLOBAL
BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 13. NORTH AMERICA
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 14. NORTH AMERICA
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 15. NORTH AMERICA
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 16. NORTH AMERICA
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 17. EUROPE
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 18. EUROPE BIOCHIPS
MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 19. EUROPE
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 20. EUROPE
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 21. ASIA PACIFIC
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 22. ASIA PACIFIC
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 23. ASIA PACIFIC
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 24. ASIA PACIFIC
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 25. LATIN AMERICA
BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 26. LATIN AMERICA
BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 27. LATIN AMERICA
BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 28. LATIN AMERICA
BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
TABLE 29. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)
TABLE 30. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)
TABLE 31. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)
TABLE 32. MIDDLE EAST
& AFRICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)
FIGURE 1. GLOBAL
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 2. PORTER’S FIVE
FORCE ANALYSIS OF BIOCHIPS MARKET
FIGURE 3. KEY IMPACT
ANALYSIS
FIGURE 4. TIMELINE OF
BIOCHIPS
FIGURE 5. MARKET
OPPORTUNITY INSIGHTS, BY REGION, 2018
FIGURE 6. MARKET
OPPORTUNITY INSIGHTS, BY TYPE, 2018
FIGURE 7. MARKET OPPORTUNITY
INSIGHTS, BY END USER, 2018
FIGURE 8. INDUSTRY
COMPONENTS OF BIOCHIPS MARKET
FIGURE 9. KEY PLAYERS
POSITIONING IN 2018 (%)
FIGURE 10. WORLDWIDE
HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)
FIGURE 11. UNITED
STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)
FIGURE 12. COMPARISON
OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE
FIGURE 13. GLOBAL
BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 14. GLOBAL DNA
CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)
FIGURE 15. GLOBAL DNA
CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)
FIGURE 16. GLOBAL DNA
CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 17. GLOBAL DNA
CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)
FIGURE 18. GLOBAL DNA
CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 19. GLOBAL DNA
CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN
$ MILLION)
FIGURE 20. GLOBAL DNA
CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 21. GLOBAL
BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 22. GLOBAL LAB
ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 23. GLOBAL LAB
ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 24. GLOBAL LAB
ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)
FIGURE 25. GLOBAL LAB
ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $
MILLION)
FIGURE 26. GLOBAL LAB
ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 27. GLOBAL LAB
ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)
FIGURE 28. GLOBAL
BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 29. GLOBAL
PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)
FIGURE 30. GLOBAL
PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)
FIGURE 31. GLOBAL
PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)
FIGURE 32. GLOBAL
PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)
FIGURE 33. GLOBAL
PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)
FIGURE 34. GLOBAL
PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 35. GLOBAL
BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)
FIGURE 36. GLOBAL OTHER
BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 37. GLOBAL OTHER
BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)
FIGURE 38. GLOBAL
BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)
FIGURE 39. GLOBAL
BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)
FIGURE 40. GLOBAL
BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)
FIGURE 41. GLOBAL
BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)
FIGURE 42. GLOBAL
BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $
MILLIONS)
FIGURE 43. GLOBAL
BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $
MILLIONS)
FIGURE 44. GLOBAL
BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)
FIGURE 45. GLOBAL
BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 46. UNITED
STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 47. CANADA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 48. UNITED
KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 49. GERMANY
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 50. FRANCE
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 51. ITALY
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 52. SPAIN
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 53. RUSSIA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 54. REST OF
EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 55. CHINA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 56. JAPAN
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 57. INDIA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 58. SOUTH KOREA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 59. ASEAN
COUNTRIES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 60. AUSTRALIA
& NEW ZEALAND BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 61. REST OF
ASIA-PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 62. BRAZIL
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 63. MEXICO
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 64. REST OF
LATIN AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 65. UNITED ARAB
EMIRATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 66. SAUDI ARABIA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 67. TURKEY BIOCHIPS
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 68. SOUTH AFRICA
BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)
FIGURE 69. REST OF
MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)